BONK, INC. current report, 22 April 2022

Full document

Filing Overview

This Form 8-K was filed by Jupiter Wellness, Inc., not BONK, Inc., on April 22, 2022, reporting events occurring April 20, 2022. The filing identifies Jupiter Wellness as a Delaware corporation with common stock and warrants listed on Nasdaq under JUPW and JUPWW.

Material Financing Transactions

  • Greentree Loan: $1.5 million convertible promissory note issued to Greentree Financial Group.
  • L&H Loan: $500,000 convertible promissory note issued to L&H.
  • Total principal financing: $2.0 million.
  • The notes mature on October 20, 2022, carry an 8% interest rate, and have a 5% original issue discount.
  • The notes are convertible at $2.79 per share, subject to downward adjustment if the company defaults.
  • The company issued warrants to purchase 1.1 million and 360,000 common shares, respectively, for an aggregate of 1.46 million shares.
  • The warrants have a five-year term, a $2.79 exercise price, cashless exercise provisions until the underlying shares are registered, and certain anti-dilution protections.
  • The company also issued an aggregate of 250,000 common shares to Greentree and L&H under the loan agreements.

Financial Metrics and Liquidity

The filing does not provide revenue, profit, cash flow, operating margin, cash balance, debt ratio, or other period-end financial statement metrics. The financing provides $2.0 million of stated principal, less the applicable 5% original issue discount, before consideration of other fees or costs not described in the filing.

Changes Versus Prior Period

The filing does not present comparative financial information or quantify changes versus a prior comparable period. It reports the creation of $2.0 million of short-term convertible debt, related warrants, and the issuance of 250,000 common shares.

Outlook, Risks, and Unusual Items

  • The notes mature approximately six months after issuance, creating a near-term repayment, refinancing, or conversion requirement.
  • Conversion of the notes and exercise of the warrants could materially dilute existing common shareholders.
  • The conversion price may be adjusted downward following a default, increasing potential dilution.
  • The warrants include anti-dilution protections and cashless exercise rights, which may affect future proceeds and dilution.
  • The filing does not provide management guidance, operating outlook, or details regarding the planned use of loan proceeds.
  • The financing and securities issuances are described as unregistered sales of equity securities.

Investor Verification Items

  • Confirm the requested company identity: the supplied metadata names BONK, Inc., while the filing names Jupiter Wellness, Inc.
  • Review the complete loan, note, and warrant agreements, including default provisions, conversion adjustments, security interests, and repayment terms.
  • Verify the 250,000-share issuance and the aggregate potential dilution from note conversions and warrant exercises.
  • Assess the company’s ability to repay or refinance the notes by the October 20, 2022 maturity date.
  • Confirm the registration status of the shares underlying the notes and warrants.